In addition, extra reports suggest that Panx1 is highly expressed in breast cancer (Stewart et al., 2016), colon cancer (Fierro-Arenas et al., 2024), and cSCC (O'Donnell, 2024), and is associated with poor prognosis in patients. Here, PANX1 is linked to malignant colon neoplasm.